Andrea Goldstein-Piekarski, PhD — Palo Alto, California

Andrea Goldstein-Piekarski, PhD is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Andrea Goldstein-Piekarski, PhD has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Alzheimer Disease, Mild Cognitive Impairment, Neuropsychiatric Symptoms.

Sponsors: Stanford University.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Andrea Goldstein-Piekarski, PhD?

Andrea Goldstein-Piekarski, PhD has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Andrea Goldstein-Piekarski, PhD conducted?

Andrea Goldstein-Piekarski, PhD has 1 clinical trials on record, with 1 currently active. Their work covers Alzheimer Disease, Mild Cognitive Impairment, Neuropsychiatric Symptoms.

Is Andrea Goldstein-Piekarski, PhD accredited by Crixeo Health?

Andrea Goldstein-Piekarski, PhD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Andrea Goldstein-Piekarski, PhD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.